['atopic dermatitis']
['opa-15406', 'placebo']

        Inclusion Criteria:

          -  Subjects 10-70 years of age

          -  Diagnosis of atopic dermatitis (AD)

          -  History of AD for at least 3 years

          -  AD affecting greater than or equal to 5% and less than or equal to 40% of total Body
             Surface Area (BSA) at Baseline

          -  Investigator's Global Assessment of Disease Severity score of 2 (mild) or 3 (moderate)
             in the selected treatment area(s)

        Exclusion Criteria:

          -  Contact or atopic dermatitis flare within 28 days of the Baseline (Day 1) visit.

          -  Concurrent diseases/conditions and history of other diseases/conditions in the
             selected treatment areas(s) that may have an impact on the study assessments.
      